Table 1

Demographic data for 248 patients treated with high-dose methotrexate and with methotrexate polyglutamate (MTXPG) accumulation data available

VariablenAverage MTXPG accumulation, pmol/109 cellsP*
Age, y 
    < 1 2145 .689 
    1-10 193 3677  
    > 10 53 3688  
Sex 
    Female 110 3307 .633 
    Male 138 3954  
Race 
    Black 49 3166 .239 
    White 199 3790  
ALL subtype 
    B-hyperdiploid 61 7028 < 10−6 
    B-other 87 3727  
    TEL-AML1 58 1960  
    T-lineage 33 1076  
    E2A-PBX1 804  
VariablenAverage MTXPG accumulation, pmol/109 cellsP*
Age, y 
    < 1 2145 .689 
    1-10 193 3677  
    > 10 53 3688  
Sex 
    Female 110 3307 .633 
    Male 138 3954  
Race 
    Black 49 3166 .239 
    White 199 3790  
ALL subtype 
    B-hyperdiploid 61 7028 < 10−6 
    B-other 87 3727  
    TEL-AML1 58 1960  
    T-lineage 33 1076  
    E2A-PBX1 804  

A total of 145, 82, and 144 of these 248 patients had leukemia cell gene expression data, 600 000 SNP chip data, and inherited 600 000 SNP chip data available, respectively.

*

P values represent the association between the variable and MTXPG accumulation in these patients.

or Create an Account

Close Modal
Close Modal